3 Stocks I Saw on T...
Health Care: Drugs
Celldex Therapeutics Inc. (CLDX: NASDAQ)
$4.08 0.09 | 2.26%
06/04/12 - 04:00 PM ET
TheStreet Ratings Grade for CLDX
| Buy | Hold | Sell | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A+ | A | A- | B+ | B | B- | C+ | C | C- | D+ | D | D- | E+ | E | E- | F |
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions.
Analyst Ratings
| Historical Rec | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago |
|---|---|---|---|---|
| Stong Buy | 7 | 6 | 5 | 5 |
| Moderate Buy | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.13 | 1.14 | 1.17 | 1.17 |
Portfolios with CLDX
- Portfolio NameUser Type
- Userbio
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor7 Cancer Drug Stocks to Kno...
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Cheap Biotech Stocks Tha...
- User3rdwavemedia Portfolio 1
- UserSUPRATRADE 7 Top Stocks for...
- UserASCO 2010
- UserSolstock
Latest CLDX Headlines from TheStreet
- ASCO '12 Stocks: Winners and Losers 06.04.12 | 06:06 am
- Biotech Stock Mailbag: ASCO, Celldex, Obesity Drug Game-Changer 05.25.12 | 05:05 am
- Celldex Targeted Drug Shrinks Breast Cancer 05.23.12 | 04:05 pm
- The Next Big Thing In Biotech: Celldex
05.18.12 | 07:05 am - 7 Stocks Under $10 Making Big Moves 05.17.12 | 12:05 pm
- Biotech Stock Live Chat Recap: ASCO & Obesity 05.17.12 | 11:05 am
- Celldex Screw-Up Nixes ASCO Data Slot 05.01.12 | 07:05 am
- Biotech Stock Mailbag: All You Need to Know About Hep C Drugs 04.13.12 | 05:04 am
- 8 Stocks Under $10 Moving Higher 03.20.12 | 12:03 pm
- Biotech Stock Chat: Recap 03.15.12 | 11:03 am
Press Releases for CLDX
- Celldex Therapeutics To Present At The Jefferies 2012 Global Healthcare Conference - Business Wire 05.31.12 | 09:05 am
- Celldex’s CDX-011 Demonstrates High Response Rates In Patients With Metastatic Breast Cancer Expressing Elevated Levels Of GPNMB And In Triple Negative Disease - Business Wire 05.23.12 | 04:05 pm
- Celldex Therapeutics To Host Call To Announce Topline Results From The EMERGE Study In Advanced Breast Cancer - Business Wire 05.18.12 | 10:05 am
- Celldex Reports First Quarter 2012 Financial Results - Business Wire 05.03.12 | 08:05 am
- Celldex Announces Plans To Release Topline Results From The EMERGE Study In Advanced Breast Cancer - Business Wire 05.01.12 | 07:05 am
- Celldex Announces Exercise Of Over-Allotment Option - Business Wire 03.14.12 | 05:03 pm
- Celldex Reports Fourth Quarter And Fiscal 2011 Financial Results - Business Wire 03.07.12 | 07:03 am
- Celldex Therapeutics To Host Corporate 2011 Year-End And 2012 Objectives Update Call - Business Wire 02.29.12 | 03:02 pm
- Celldex Therapeutics To Present At The Citi 2012 Global Health Care Conference - Business Wire 02.24.12 | 10:02 am
- Celldex Prices Public Offering Of Common Stock - Business Wire 02.24.12 | 09:02 am
Partner Headlines for CLDX
- IsoRay: A Potential Small-Cap Bio-Pharma Multi-Bagger - Seeking Alpha 05.29.12 | 09:05 am
- Pre-Market Most Active for May 24, 2012 : BAC, PPL, EMC, NTAP, HPQ, MTGE, CLDX, TS, FB, MT, QQQ, VOD - NASDAQ 05.24.12 | 12:05 pm
- Analyst Insights: Celldex, InterMune, American Tower, Thermo Fisher, Jiayuan.com May 24th - Wall St. Cheat Sheet 05.24.12 | 11:05 am
- After Hours Most Active for May 23, 2012 : NTAP, HPQ, BAC, BLK, IFSIA, QQQ, F, CLDX, KMI, PFE, ERIC, FB - NASDAQ 05.23.12 | 08:05 pm
- Breast Cancer Immunotherapy: A New Hope In The Fight - Seeking Alpha 03.09.12 | 08:03 am
- Notable Put Options Activity in Celldex Therapeutics - Benzinga 03.06.12 | 01:03 pm
- Notable Put Options Activity in Celldex Therapeutics - Benzinga 02.27.12 | 01:02 pm
- Immunocellular Again Pushing To $2 - Seeking Alpha 02.15.12 | 09:02 am
- 10 Biotech Stocks With 100% Upside In 2012: Part One - Seeking Alpha 02.09.12 | 10:02 am
- Biotech Stocks To Watch In 2012 - Seeking Alpha 02.06.12 | 09:02 am
